Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasms 1

Interventions

icotinib 1abarelix 1Surgical Procedures, Operative 1Prednisone 1Oxycodone 1Oxaliplatin 1Morphine 1Leucovorin 1Irinotecan 1Fluorouracil 1Fentanyl 1Erlotinib Hydrochloride 1Congresses as Topic 1Clinical Protocols 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × abarelix × Clear all
NCT00103623 2006-09-19

The Plenaxis® Experience Study

PRAECIS Pharmaceuticals Inc.

Phase 4 Suspended
2,000 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡